SAN DIEGO & MADRID, Spain--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ:CYTX) (FWB:XMPA) entered into an agreement with MBA Grupo, a European healthcare distributor, who will distribute the Celution™ System in Spain, Italy and Portugal starting early 2008 for reconstructive surgery applications. MBA Grupo will oversee product sales, education and training for breast reconstruction following partial mastectomy initially, and for other reconstructive applications in the future. Cytori’s Celution™ System is an innovative medial device that removes a patient’s own stem and regenerative cells from their fat tissue. The cells can then be delivered to the same patient in about an hour.
